CHUK(也称为IKKα或IKK1)是IκB激酶(IKK)复合物的一个关键亚基,属于IKK蛋白激酶家族。该家族还包括IKKβ(IKK2)和IKKγ(NEMO),它们共同参与调控NF-κB信号通路,这是细胞中重要的炎症、免疫反应和细胞存活的调控途径。CHUK的主要功能是通过磷酸化IκB蛋白(NF-κB的抑制因子),促进IκB的降解,从而释放NF-κB进入细胞核激活靶基因的转录。CHUK不仅在经典NF-κB通路中发挥作用,还参与非经典NF-κB通路的激活,特别是在淋巴器官发育和表皮分化中起关键作用。CHUK的突变或功能异常与多种疾病相关,例如其功能丧失突变可能导致罕见的遗传性疾病,如外胚层发育不良伴免疫缺陷,表现为皮肤异常、毛发缺失和免疫系统功能受损。此外,CHUK的异常表达还与炎症性疾病、自身免疫疾病和某些癌症(如乳腺癌和鳞状细胞癌)的发生发展相关。CHUK过表达可能导致NF-κB信号通路的持续激活,进而促进炎症反应和细胞增殖,增加肿瘤发生的风险;而CHUK表达降低则可能削弱免疫反应和表皮屏障功能,导致感染易感性和皮肤病变。在基因家族中,IKK成员均含有激酶结构域,能够通过磷酸化作用调控下游信号分子,但CHUK与IKKβ在功能上有所分工,CHUK更侧重于非经典通路和发育调控,而IKKβ主要参与炎症和免疫反应的经典通路。研究CHUK的功能和调控机制对于理解炎症、免疫相关疾病及癌症的发病机制具有重要意义,同时也为开发靶向药物提供了潜在方向。
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008]
该基因编码的丝氨酸/苏氨酸蛋白激酶家族的一个成员。编码的蛋白质,细胞因子活化的蛋白复合物,它是必不可少的转录因子NF-κ-B复合的抑制剂的组分,磷酸经由泛素化途径触发抑制剂的降解,从而激活转录因子的网站。 [由RefSeq的,2008年7月提供]
CHUK基因(以及对应的蛋白质)的细胞分布位置:
CHUK基因的本体(GO)信息:
名称 |
---|
4014 Ras signaling pathway [PATH:hsa04014] |
4010 MAPK signaling pathway [PATH:hsa04010] |
4064 NF-kappa B signaling pathway [PATH:hsa04064] |
4668 TNF signaling pathway [PATH:hsa04668] |
4068 FoxO signaling pathway [PATH:hsa04068] |
4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
4210 Apoptosis [PATH:hsa04210] |
4620 Toll-like receptor signaling pathway [PATH:hsa04620] |
4621 NOD-like receptor signaling pathway [PATH:hsa04621] |
4622 RIG-I-like receptor signaling pathway [PATH:hsa04622] |
4623 Cytosolic DNA-sensing pathway [PATH:hsa04623] |
4660 T cell receptor signaling pathway [PATH:hsa04660] |
4662 B cell receptor signaling pathway [PATH:hsa04662] |
4062 Chemokine signaling pathway [PATH:hsa04062] |
4920 Adipocytokine signaling pathway [PATH:hsa04920] |
4380 Osteoclast differentiation [PATH:hsa04380] |
5200 Pathways in cancer [PATH:hsa05200] |
5212 Pancreatic cancer [PATH:hsa05212] |
5221 Acute myeloid leukemia [PATH:hsa05221] |
5220 Chronic myeloid leukemia [PATH:hsa05220] |
5215 Prostate cancer [PATH:hsa05215] |
5222 Small cell lung cancer [PATH:hsa05222] |
5120 Epithelial cell signaling in Helicobacter pylori infection [PATH:hsa05120] |
5131 Shigellosis [PATH:hsa05131] |
5166 HTLV-I infection [PATH:hsa05166] |
5162 Measles [PATH:hsa05162] |
5161 Hepatitis B [PATH:hsa05161] |
5160 Hepatitis C [PATH:hsa05160] |
5168 Herpes simplex infection [PATH:hsa05168] |
5169 Epstein-Barr virus infection [PATH:hsa05169] |
5145 Toxoplasmosis [PATH:hsa05145] |
5142 Chagas disease (American trypanosomiasis) [PATH:hsa05142] |
名称 |
---|
Activated TLR4 signalling |
Activation of NF-kappaB in B cells |
Adaptive Immune System |
AKT phosphorylates targets in the cytosol |
C-type lectin receptors (CLRs) |
CLEC7A (Dectin-1) signaling |
Constitutive Signaling by AKT1 E17K in Cancer |
Cytokine Signaling in Immune system |
Cytosolic sensors of pathogen-associated DNA |
DAP12 interactions |
DAP12 signaling |
Dectin-1 mediated noncanonical NF-kB signaling |
Disease |
Diseases associated with the TLR signaling cascade |
Diseases of Immune System |
Diseases of signal transduction |
Downstream signal transduction |
Downstream signaling events of B Cell Receptor (BCR) |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
Downstream TCR signaling |
Fc epsilon receptor (FCERI) signaling |
FCERI mediated NF-kB activation |
GAB1 signalosome |
IkBA variant leads to EDA-ID |
IKBKB deficiency causes SCID |
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) |
IKK complex recruitment mediated by RIP1 |
Immune System |
Innate Immune System |
Interleukin-1 signaling |
IRAK1 recruits IKK complex |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation |
MyD88 cascade initiated on plasma membrane |
MyD88 dependent cascade initiated on endosome |
MyD88-independent TLR3/TLR4 cascade |
MyD88:Mal cascade initiated on plasma membrane |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
NGF signalling via TRKA from the plasma membrane |
NOD1/2 Signaling Pathway |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
PI-3K cascade:FGFR1 |
PI-3K cascade:FGFR2 |
PI-3K cascade:FGFR3 |
PI-3K cascade:FGFR4 |
PI3K events in ERBB2 signaling |
PI3K events in ERBB4 signaling |
PI3K/AKT activation |
PI3K/AKT Signaling in Cancer |
PIP3 activates AKT signaling |
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
RIP-mediated NFkB activation via ZBP1 |
Role of LAT2/NTAL/LAB on calcium mobilization |
Signal Transduction |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR1 |
Signaling by FGFR2 |
Signaling by FGFR3 |
Signaling by FGFR4 |
Signaling by Interleukins |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by the B Cell Receptor (BCR) |
Signalling by NGF |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
TCR signaling |
Toll Like Receptor 10 (TLR10) Cascade |
Toll Like Receptor 2 (TLR2) Cascade |
Toll Like Receptor 3 (TLR3) Cascade |
Toll Like Receptor 4 (TLR4) Cascade |
Toll Like Receptor 5 (TLR5) Cascade |
Toll Like Receptor 7/8 (TLR7/8) Cascade |
Toll Like Receptor 9 (TLR9) Cascade |
Toll Like Receptor TLR1:TLR2 Cascade |
Toll Like Receptor TLR6:TLR2 Cascade |
Toll-Like Receptors Cascades |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
TRAF6 Mediated Induction of proinflammatory cytokines |
TRAF6 mediated NF-kB activation |
TRIF-mediated TLR3/TLR4 signaling |
ZBP1(DAI) mediated induction of type I IFNs |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
COCOON SYNDROME | 0.320271442 | 1 | 1 | BeFree_CLINVAR_CTD_human_MGD |
Bone Diseases, Developmental | 0.12 | 1 | 0 | CTD_human |
Skin Abnormalities | 0.12 | 3 | 0 | CTD_human |
Fetal Diseases | 0.12 | 4 | 0 | CTD_human |
Cleft Palate | 0.12 | 1 | 0 | CTD_human |
Limb Deformities, Congenital | 0.12 | 4 | 0 | CTD_human |
IGA Glomerulonephritis | 0.12 | 1 | 0 | CTD_human |
Muscular Atrophy | 0.08 | 1 | 0 | RGD |
Colitis | 0.08 | 1 | 0 | RGD |
Prostatic Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。